Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization

Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization

The purpose of this study was to investigate whether ultra-high-field dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the breast at 7T using quantitative pharmacokinetic (PK) analysis can differentiate between benign and malignant breast tumors for improved breast cancer diagnosis...

Full description

Bibliographic Details
Main Authors: R. Elena Ochoa-Albiztegui, Varadan Sevilimedu, Joao V. Horvat, Sunitha B. Thakur, Thomas H. Helbich, Siegfried Trattnig, Elizabeth A. Morris, Jeffrey S. Reiner, Katja Pinker
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
breast cancer
ultra-high-field magnetic resonance imaging
quantitative pharmacokinetics
immunohistochemistry
molecular subtypes
proliferation rate
Online Access:https://www.mdpi.com/2072-6694/12/12/3763

Internet

https://www.mdpi.com/2072-6694/12/12/3763

Similar Items